Picture of Ginkgo Bioworks Holdings logo

DNA — Ginkgo Bioworks Holdings News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: Ginkgo Bioworks Receives Grant To Develop Live Cell Delivery Platform Of Antibody Therapeutics For Treating HIV And Malaria

Dec 13 (Reuters) - Ginkgo Bioworks Holdings Inc  DNA.N :
    * GINKGO BIOWORKS RECEIVES GRANT TO DEVELOP INNOVATIVE LIVE
CELL
DELIVERY PLATFORM OF ANTIBODY THERAPEUTICS FOR TREATING HIV AND
MALARIA
    * GINKGO - WILL FOCUS ON CREATING PROTOTYPE ENGINEERED CELL
LINE
THAT CAN EXPRESS ANTIBODIES FOR TREATMENT OF HIV AND/OR MALARIA
VIA IMPLANTABLE DEVICE

Source text for Eikon:  ID:nPnbJVnQya 
Further company coverage:  DNA.N 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Ginkgo Bioworks Holdings

See all news